Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive ibuprofen for adult pulmonary tuberculosis
ChiCTR1800016451Phase 2Not yet recruiting
- Sponsor
- Ankang Central Hospital
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ibuprofen in pulmonary tuberculosis (TB) (2 arms), sponsored by Ankang Central Hospital. Primary endpoint: Sputum mycobacterial load. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
ibuprofen
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR1800016451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016451.